Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 80,000,000
- Total 13F shares
- 50,188,683
- Share change
- +724,614
- Total reported value
- $1,702,972,802
- Put/Call ratio
- 103%
- Price per share
- $33.93
- Number of holders
- 148
- Value change
- +$19,493,416
- Number of buys
- 77
- Number of sells
- 70
Report period
Q2 2023
Institutions
148
Top holders
10
CLDX full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117B202
Recent filing periods:
Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
8.9%
|
7,081,078
|
$254,777,186 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.2%
|
4,181,611
|
$150,454,364 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
3,250,638
|
$116,957,955 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.9%
|
3,084,215
|
$110,970,056 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
2,548,598
|
$91,698,556 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
2,302,525
|
$82,844,558 | — | 31 Mar 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.8%
|
2,267,989
|
$81,602,244 | — | 31 Mar 2023 | |
| Redmile Group, LLC |
13F
|
Company |
2.3%
|
1,879,739
|
$67,633,009 | — | 31 Mar 2023 | |
| Bellevue Group AG |
13F
|
Company |
2.2%
|
1,800,000
|
$64,764,000 | — | 31 Mar 2023 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.2%
|
1,734,972
|
$62,424,293 | — | 31 Mar 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2%
|
1,582,090
|
$56,923,600 | — | 31 Mar 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.8%
|
1,409,451
|
$50,712,047 | — | 31 Mar 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,377,740
|
$49,571,085 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
1,335,546
|
$48,052,945 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
925,708
|
$33,306,986 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.97%
|
779,628
|
$28,051,015 | — | 31 Mar 2023 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.95%
|
759,898
|
$27,341,130 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.89%
|
713,562
|
$25,675,000 | — | 31 Mar 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.86%
|
689,676
|
$24,814,542 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.74%
|
595,509
|
$19,721,491 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.62%
|
498,754
|
$17,944,783 | — | 31 Mar 2023 | |
| Commodore Capital LP |
13F
|
Company |
0.62%
|
495,823
|
$17,839,712 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.62%
|
493,045
|
$17,739,760 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
480,553
|
$17,290,297 | — | 31 Mar 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.53%
|
421,504
|
$15,165,714 | — | 31 Mar 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.52%
|
419,397
|
$15,089,904 | — | 31 Mar 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
364,273
|
$13,106,543 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
361,517
|
$13,007,382 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
360,173
|
$12,959,024 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
346,723
|
$12,475,094 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.42%
|
333,666
|
$12,005,303 | — | 31 Mar 2023 | |
| TSP Capital Management Group, LLC |
13F
|
Company |
0.32%
|
252,395
|
$9,081,173 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.29%
|
229,503
|
$8,257,518 | — | 31 Mar 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.21%
|
165,728
|
$5,947,042 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
165,068
|
$5,939,147 | — | 31 Mar 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
145,736
|
$5,243,581 | — | 31 Mar 2023 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.16%
|
125,300
|
$4,508,294 | — | 31 Mar 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.15%
|
121,500
|
$4,371,570 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
120,548
|
$4,337,000 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.15%
|
117,905
|
$4,242,222 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.14%
|
112,560
|
$4,049,909 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.14%
|
109,024
|
$3,922,683 | — | 31 Mar 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.13%
|
106,057
|
$3,815,932 | — | 31 Mar 2023 | |
| Mirador Capital Partners LP |
13F
|
Company |
0.13%
|
100,889
|
$3,629,986 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.12%
|
95,156
|
$3,423,713 | — | 31 Mar 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.12%
|
94,601
|
$3,403,744 | — | 31 Mar 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.12%
|
92,129
|
$3,314,802 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.11%
|
91,583
|
$3,295,156 | — | 31 Mar 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
84,651
|
$3,045,743 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
81,400
|
$2,928,772 | — | 31 Mar 2023 |
Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) as of Q2 2023
As of 30 Jun 2023,
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,188,683 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, BlackRock Inc., STATE STREET CORP, Kynam Capital Management, LP, VANGUARD GROUP INC, Polar Capital Holdings Plc, Bellevue Group AG, and PICTET ASSET MANAGEMENT SA.
This page lists
149
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
158
Q2 2023 holders
148
Holder diff
-10
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.